Tucotuzumab celmoleukin: Difference between revisions

Jump to navigation Jump to search
m (Protected "Tucotuzumab celmoleukin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
Line 26: Line 26:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 32: Line 32:


{{humanizedmonoclonals}}
{{humanizedmonoclonals}}
{{SIB}}
 
[[Category:Monoclonal antibodies]]
[[Category:Monoclonal antibodies]]
[[Category:Cancer treatments]]
[[Category:Cancer treatments]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 17:09, 20 August 2012

Template:Drugbox-mab

WikiDoc Resources for Tucotuzumab celmoleukin

Articles

Most recent articles on Tucotuzumab celmoleukin

Most cited articles on Tucotuzumab celmoleukin

Review articles on Tucotuzumab celmoleukin

Articles on Tucotuzumab celmoleukin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tucotuzumab celmoleukin

Images of Tucotuzumab celmoleukin

Photos of Tucotuzumab celmoleukin

Podcasts & MP3s on Tucotuzumab celmoleukin

Videos on Tucotuzumab celmoleukin

Evidence Based Medicine

Cochrane Collaboration on Tucotuzumab celmoleukin

Bandolier on Tucotuzumab celmoleukin

TRIP on Tucotuzumab celmoleukin

Clinical Trials

Ongoing Trials on Tucotuzumab celmoleukin at Clinical Trials.gov

Trial results on Tucotuzumab celmoleukin

Clinical Trials on Tucotuzumab celmoleukin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tucotuzumab celmoleukin

NICE Guidance on Tucotuzumab celmoleukin

NHS PRODIGY Guidance

FDA on Tucotuzumab celmoleukin

CDC on Tucotuzumab celmoleukin

Books

Books on Tucotuzumab celmoleukin

News

Tucotuzumab celmoleukin in the news

Be alerted to news on Tucotuzumab celmoleukin

News trends on Tucotuzumab celmoleukin

Commentary

Blogs on Tucotuzumab celmoleukin

Definitions

Definitions of Tucotuzumab celmoleukin

Patient Resources / Community

Patient resources on Tucotuzumab celmoleukin

Discussion groups on Tucotuzumab celmoleukin

Patient Handouts on Tucotuzumab celmoleukin

Directions to Hospitals Treating Tucotuzumab celmoleukin

Risk calculators and risk factors for Tucotuzumab celmoleukin

Healthcare Provider Resources

Symptoms of Tucotuzumab celmoleukin

Causes & Risk Factors for Tucotuzumab celmoleukin

Diagnostic studies for Tucotuzumab celmoleukin

Treatment of Tucotuzumab celmoleukin

Continuing Medical Education (CME)

CME Programs on Tucotuzumab celmoleukin

International

Tucotuzumab celmoleukin en Espanol

Tucotuzumab celmoleukin en Francais

Business

Tucotuzumab celmoleukin in the Marketplace

Patents on Tucotuzumab celmoleukin

Experimental / Informatics

List of terms related to Tucotuzumab celmoleukin


Overview

Tucotuzumab celmoleukin is a humanized monoclonal antibody used to treat cancer. Tucotuzumab has a chelator, celmoleukin.

Template:Humanizedmonoclonals Template:WH Template:WS